BRCA: Who Should Be Tested?

MARISOL ROSAS ​was 8 years old when her mother, Celia Bazua de Rosas, died from ovarian cancer in 1981. It was her mother’s second cancer diagnosis. She had been diagnosed with breast cancer at age 42, shortly after Rosas, her sixth and last child, was born. For Rosas and her brothers and sisters, who were all raised in Baja California, Mexico, “there was always a concern,” she says, “that this could happen to any of us.” ​

As the siblings got older, their worries grew as three cousins on their mother’s side of the family were diagnosed with cancer. “One had breast cancer that spread to her brain,” says Rosas. “Another had breast cancer and then had a recurrence. Another had breast and ovarian cancer and then died of pancreatic cancer. I knew there was something going on, but I didn’t know what to do about it.”

Then, in 1998, Rosas got a call from a cousin who had moved from Mexico to California. Her cousin explained that her doctor had told her about a new blood test that could look for signs of an increased risk for breast or ovarian cancer. Her test had come back positive. She was calling to tell Rosas that she and her siblings should get tested, too.

Read the full story in the Winter 2019/2020 Issue of Cancer Today.

All About Overdiagnosis

For the Fall 2016 issue of Cancer Today, I spoke with epidemiologist Pam Marcus on why cancer screening can have risks.

14-qa-with-pam-marcus-stock-art250x200-webAs my article notes, the premise of cancer screening seems straightforward: Save lives by finding cancers before they start causing symptoms, when they are smaller and often easier to treat.

But as scientists have learned more about how tumors grow and spread, the road from cancer screening to saving lives has taken unexpected twists and turns. Some cancers spread to other parts of the body while still small. Others are so aggressive that finding them early doesn’t change the outcome. And still others might never need to be found, or treated, at all.

This doesn’t mean cancer screening has no value. But it does mean that potential benefits must be weighed against risks. Read the full Q&A.

‘Sir’ and ‘Ladies’: Can We Tell You About Cancer?

On the international front, a brief article I wrote on a cancer education campaign in Ghana: ‘Sir’ and ‘Ladies’: Can We Tell You About Cancer?

The Africa Oxford Cancer Foundation and the European Society for Medical Oncology Developing Countries Task Force launched a five-year pilot program in Ghana to develop and implement cancer-prevention and early-detection programs that can be models for other developing countries.

Afrox1Currently, most Africans do not have access to screening, treatment or palliative care. For instance, Ghana, with a population of 25.9 million, has only two oncology centers and four oncologists. There are no oncology nurses.

Afrox2The pilot program includes the distribution of 13 different posters (like those seen here) to health centers  and the general public. Developed with the support of the Cancer Society of Ghana, the posters can be downloaded for free and used by any organization or individual, and in any country.

This article originally appeared in the Winter 2014/2015 Cancer Today.

Elmer Huerta: A Champion for Prevention

6-Elmer-Huerta-200x250-WEB

Dr. Elmer Huerta is the founder of the Cancer Preventiorium, a cancer prevention clinic specifically for Latino immigrants. Since opening its doors in the mid-1990s at the Washington Cancer Institute in Washington, DC, the Preventorium has served close to 33,000 people.

How did the Cancer Preventorium get started?
While Dr. Huerta was at the National Cancer Institute, he started a radio show, Cuidando su Salud (Taking Care of Your Health), and as his show became more popular, he was asked to provide cancer prevention presentations at Latino churches and community centers. In these settings, women frequently shared their frustrations about having to go to one doctor for a Pap test, another for a colorectal cancer screening test and then yet another so their husband could have prostate cancer screening. They wanted everything in one place. Dr. Huerta thought they were on to something—and Washington Hospital agreed. “The interest of the community was so huge,” says Huerta, “we started then and haven’t stopped.”

Read more about the Cancer Preventorium in my interview with Dr. Huertra  in the Winter 2014/2015 Cancer Today.